10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-058207`
Period End Date	20230930
Filing Date	20231102
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	alhc-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 84 Cash Flow Statement 93 Stockholders Equity 32

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$91.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$567.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $91 at September 30, 2023 and $0 at December 31, 2022, respectively)	`AccountsReceivableNetCurrent`	$92.89M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $91 at September 30, 2023 and $0 at December 31, 2022, respectively)	`AccountsReceivableNetCurrent`	$105.52M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$123.93M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.11M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$45.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$544.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$666.97M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$37.17M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$47.16M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	188.91M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.28M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$10.47M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	188.91M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$5.83M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$40.29M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$40.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.08M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.04M	USD	Point-in-time
Total assets	`Assets`	$633.86M	USD	Point-in-time
Total assets	`Assets`	$770.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$203.44M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$170.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$25.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.98M	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$146.34M	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$308.00K	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$35.14M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$27.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$229.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$410.27M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$160.90M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.59M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.70M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$9.32M	USD	Point-in-time
Total liabilities	`Liabilities`	$394.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$581.19M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 188,911,520 and 187,280,015 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 188,911,520 and 187,280,015 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$970.18M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-732.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-833.05M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$238.13M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$188.50M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$770.79M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$633.86M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$359.98M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$1.34B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.07B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$450.24M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$16.32M	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$898.00K	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$6.47M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$370.00K	USD	1 Quarter
Total revenues	`Revenues`	$1.36B	USD	3 Qtrs
Total revenues	`Revenues`	$1.07B	USD	3 Qtrs
Total revenues	`Revenues`	$360.35M	USD	1 Quarter
Total revenues	`Revenues`	$456.71M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$312.85M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$397.88M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$923.88M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$1.20B	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$212.42M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$223.70M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$83.09M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$76.45M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.46M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.61M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.59M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.50M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$393.76M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$486.46M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.15B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$1.44B	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-29.76M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-85.90M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-33.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-76.53M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.61M	USD	1 Quarter
Interest expense	`InterestExpense`	$15.75M	USD	3 Qtrs
Interest expense	`InterestExpense`	$13.50M	USD	3 Qtrs
Interest expense	`InterestExpense`	$5.47M	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$252.00K	USD	3 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-145.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-131.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-711.00K	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-5.32M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-15.94M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-6.67M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-15.04M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-35.08M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-100.94M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-92.48M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$167.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$167.00K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-40.25M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-92.64M	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-30.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-134.00K	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-40.25M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-35.05M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-92.64M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-100.81M	USD	3 Qtrs
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	185.49M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	182.12M	shares	1 Quarter
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	180.77M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	187.33M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	180.77M	shares	3 Qtrs
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	182.12M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	185.49M	shares	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.54	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.19	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.19	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.54	USD	3 Qtrs

Cash Flow Statement 93 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-40.25M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-92.64M	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$150.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$40.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$39.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$91.00K	USD	3 Qtrs
(Gain) loss on sublease	`GainLossOnSublease`	$289.00K	USD	3 Qtrs
(Gain) loss on sublease	`GainLossOnSublease`	$-510.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$15.81M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.73M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$3.35M	USD	3 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$8.00K	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.04M	USD	3 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.62M	USD	3 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	-	USD	3 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	$2.94M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$58.83M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$51.18M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$2.15M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.65M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.72M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.84M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.77M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.74M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$119.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$137.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$45.51M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$33.30M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.03M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-4.61M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$116.30M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$146.03M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.48M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.60M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.62M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.13M	USD	3 Qtrs
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	-	USD	3 Qtrs
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	$-14.12M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$128.28M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$103.84M	USD	3 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	3 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$2.39M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$281.58M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$2.83M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$160.74M	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$2.42M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-17.32M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-25.40M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-146.25M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.11M	USD	3 Qtrs
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	$100.00K	USD	3 Qtrs
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	3 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$165.00M	USD	3 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$4.60M	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$143.18M	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	3 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.12M	USD	3 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-17.91M	USD	3 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$100.85M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$13.94M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$22.45M	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$117.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$290.00K	USD	3 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	3 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$375.00K	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$567.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$391.64M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$393.39M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	188.91M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Net loss	`ProfitLoss`	$-40.25M	USD	1 Quarter
Net loss	`ProfitLoss`	$-100.94M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-35.08M	USD	1 Quarter
Net loss	`ProfitLoss`	$-92.64M	USD	3 Qtrs
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$1.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$2.00K	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$13.57M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$51.18M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$58.83M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.69M	USD	1 Quarter
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$100.00K	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	3 Qtrs
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$189.60M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	188.91M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.